P1161 PERI-TRANSPLANT TREATMENT WITH ANTI-HCV E2 HUMAN MONOCLONAL ANTIBODY MBL-HCV1 IN COMBINATION WITH A PROTEASE INHIBITOR RESULTS IN UNDETECTABLE HCVRNA IN THE EARLY POST-TRANSP... von Curry, M.P, Smith, H.L, Chung, R.T, Schiano, T.D, Chapman, W.C, Mantry, P.S, Brown, K.A, Molrine, D.C

Volltext

281 SAFETY AND PHARMACOKINETICS OF A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (MBL-HCV1) IN HEALTHY VOLUNTEERS von Leav, B.A, Sloan, S, Blair, B.M, Cheslock, P, Knauber, M, Ambrosino, D.M, Molrine, D.C

Volltext

1048 A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (HCV) PREVENTS INFECTION IN CHIMPANZEES von Blair, B.M, Broering, T.J, Babcock, G.J, Szabo, G, Finberg, R.W, Cheslock, P.S, Knauber, M, Leav, B.A, Lanford, R, Purcell, R.H, Ambrosino, D.M, Molrine, D.C

Volltext

Impaired human responses to tetanus toxoid in vitamin A-deficient SCID mice reconstituted with human peripheral blood lymphocytes von Molrine, D.C. (Dana-Farber Center Institute, Boston, MA.), Polk, D.B, Ciamarra, A, Phillips, N, Ambrosino, D.M

Volltext